AI assistant
Sending…
XERO LIMITED — Director's Dealing 2015
Aug 13, 2015
66106_rns_2015-08-13_1782e968-a053-476c-8c47-97313aa15074.pdf
Director's Dealing
Open in viewerOpens in your device viewer
DocuSign Envelope ID: 6A3DCE64-8FD2-4448-BBF9-91A7AD376B4A
==> picture [112 x 28] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | |||||||
| Name of listed issuer: | Xero Limited(XRO) | ||||||
| Date this disclosure made: | 14 |
August 2015 | |||||
| Date of last disclosure: | 7 April 2015 | ||||||
| Director or senior managergiving disclosure | |||||||
| Full name(s): | Duncan Ritchie | ||||||
| Name of listed issuer: | Xero Limited(XRO) | ||||||
| Name of related body corporate (if applicable): | Not | applicable | |||||
| Position held in listed issuer: | Chief Platform Officer | ||||||
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) | ||
|---|---|---|
| Class of affected quoted financial products: | Ordinary shares in Xero Limited (Ordinary Shares) |
|
| Nature of the affected relevant interest(s): | Beneficial ownership of Ordinary Shares through the Xero Limited Employee Restricted Share Plan |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 67,549 Ordinary Shares (Duncan Ritchie also has legal ownership of 34,903 Ordinary Shares) |
|
| Number held in class after acquisition or disposal: | 72,964 Ordinary Shares (Duncan Ritchie's legal ownership of 34,903 Ordinary Shares remains unchanged) |
|
| Current registered holder(s): | Xero Trustee Limited | |
| Registered holder(s) once transfers are registered: | Xero Trustee Limited |
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
Not applicable |
|---|---|---|
| A statement as to whether the derivative is cash settled or physicallysettled: | Not applicable | |
| Maturitydate of the derivative(if any): | Not applicable | |
| Expirydate of the derivative(if any): | Not applicable | |
| Theprice specified in the terms of the derivative(if any): | Not applicable | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: |
Not applicable | |
| For that derivative,- Parties to the derivative: Not applicable If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: Not applicable |
||
| Parties to the derivative: | Not applicable | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
Not applicable |
DocuSign Envelope ID: 6A3DCE64-8FD2-4448-BBF9-91A7AD376B4A
| ocuSign Envelope ID: 6A3DCE64-8FD2-4448-BBF9-91A7AD376B4A | ocuSign Envelope ID: 6A3DCE64-8FD2-4448-BBF9-91A7AD376B4A | ||||||
|---|---|---|---|---|---|---|---|
| Details of transactions giving rise to acquisition or disposal | |||||||
| Total number of transactions to which notice relates: | 1 | ||||||
| Details of transactions requiring disclosure- | |||||||
| Date of transaction: | 10 August 2015 | ||||||
| Allocation of Ordinary Shares | |||||||
| Nature of transaction: | under the Xero Limited Employee Restricted Share |
||||||
| Plan | |||||||
| Name of any other party or parties to the transaction (if known): | Not applicable | ||||||
| The consideration, expressed in New Zealand dollars, paid or received for the acquisition or | Ordinary Shares allocated, as part of the remuneration package of Duncan Ritchie at a value of NZ$17.64 per |
||||||
| disposal. If the consideration was not in cash and cannot be readily by converted into a cash | share (being the 20 day value | ||||||
| value, describe the consideration: | weighted average market price of Ordinary Shares on the NZX Main Board through to 7 August 2015) |
||||||
| Number of financial products to which the transaction related: | 1 | ||||||
| If the issuer has a financial products trading policy that prohibits directors or senior managers | |||||||
| from trading during any period without written clearance (a closed period) include the following | |||||||
| details— | |||||||
| Whether relevant interests were acquired or disposed of during a closed period: | Not applicable | ||||||
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: |
Not applicable | ||||||
| Date of the prior written clearance (if any): | Not applicable | ||||||
| Summary of other relevant interests after acquisition or disposal: | |||||||
| Class of quoted financial products: | Ordinary Shares | ||||||
| Nature of relevant interest: | Legal ownership of Ordinary Shares |
||||||
| For that relevant interest,- | |||||||
| Number held in class: | 34,903 | ||||||
| Current registered holder(s): | Duncan Ritchie | ||||||
| For a derivative relevant interest,- | |||||||
| Type of derivative: | Not applicable | ||||||
| Details of derivative,- | |||||||
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
Not applicable | ||||||
| A statement as to whether the derivative is cash settled or physically settled: | Not applicable | ||||||
| Maturity date of the derivative (if any): | Not applicable | ||||||
| Expiry date of the derivative (if any): | Not applicable | ||||||
| The price's specified terms (if any): | Not applicable | ||||||
| Any other details needed to understand how the amount of the consideration payable under the | |||||||
| derivative or the value of the derivative is affected by the value of the underlying financial | Not applicable | ||||||
| products: | |||||||
| For that derivative relevant interest,- | Not applicable | ||||||
| Parties to the derivative: | Not applicable | ||||||
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
Not applicable | ||||||
| Certification |
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
DocuSign Envelope ID: 6A3DCE64-8FD2-4448-BBF9-91A7AD376B4A
Signature of director or officer: Date of signature:
14 August 2015
More from XERO LIMITED
Regulatory Filings
2026
Jun 2
Regulatory Filings
2026
Jun 2
Share Issue/Capital Change
2026
May 27
Major Shareholding Notification
2026
May 25
Governance Information
2026
May 13
Earnings Release
2026
May 13
Investor Presentation
2026
May 13
Environmental & Social Information
2026
May 13
Annual Report
2026
May 13
Share Issue/Capital Change
2026
Apr 30